{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:42:45Z","timestamp":1790678565116,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jogc.2022.08.018","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T08:29:07Z","timestamp":1662971347000},"page":"1174-1180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Outcome and Management of Serous Tubal Intraepithelial Carcinoma Following Opportunistic Salpingectomy: Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"44","author":[{"given":"Jessica","family":"Ruel-Lalibert\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Medina","family":"Kasasni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Oprea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Viau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2022.08.018_bib1","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/j.jogc.2018.01.016","article-title":"No. 230-initial evaluation and referral guidelines for management of pelvic\/ovarian masses","volume":"40","author":"Le","year":"2018","journal-title":"J\u00a0Obstet Gynecol Can"},{"key":"10.1016\/j.jogc.2022.08.018_bib2","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1371\/journal.pmed.0050232","article-title":"Ovarian carcinoma subtypes are different diseases: implications for biomarker studies","volume":"5","author":"K\u00f6bel","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.jogc.2022.08.018_bib3","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jogc.2022.08.018_bib4","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/1471-0528.14543","article-title":"Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review","volume":"124","author":"Chen","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2022.08.018_bib5","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/IGC.0000000000000920","article-title":"Serous tubal intraepithelial carcinoma associated with extraovarian metastases","volume":"27","author":"Schneider","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogc.2022.08.018_bib6","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","article-title":"New insights into the pathogenesis of serous ovarian cancer and its clinical impact","volume":"26","author":"Levanon","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jogc.2022.08.018_bib7","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/GRF.0000000000000316","article-title":"Management of preinvasive lesions","volume":"60","author":"Patrono","year":"2017","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jogc.2022.08.018_bib8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/annonc\/mdz062","article-title":"ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","volume":"30","author":"Colombo","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jogc.2022.08.018_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/diagnostics10020102","article-title":"Serous tubal intraepithelial carcinoma: a concise review for the practicing pathologist and clinician","volume":"10","author":"Bachert","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jogc.2022.08.018_bib10","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ygyno.2015.09.018","article-title":"Clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): a comprehensive review","volume":"139","author":"Patrono","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2022.08.018_bib11","first-page":"625","article-title":"STICS, SCOUTs and p53 signatures; a new language for pelvic serous carcinogenesis","volume":"3","author":"Mehra","year":"2011","journal-title":"Front Biosci Elite Ed"},{"key":"10.1016\/j.jogc.2022.08.018_bib12","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/modpathol.2009.89","article-title":"Candidate serous cancer precursors in fallopian tube epithelium of BRCA1\/2 mutation carriers","volume":"22","author":"Shaw","year":"2009","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.jogc.2022.08.018_bib13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ygyno.2019.03.003","article-title":"Retrospective study of a 16 year cohort of BRCA1 and BRCA2 carriers presenting for RRSO: Prevalence of invasive and in-situ carcinoma, with follow-up","volume":"153","author":"Blok","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2022.08.018_bib14","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1080\/14737140.2016.1247699","article-title":"Serous tubal intraepithelial carcinoma (STIC) - clinical impact and management","volume":"16","author":"Weinberger","year":"2016","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.jogc.2022.08.018_bib15","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2022.08.018_bib16","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jogc.2022.08.018_bib17","author":"Wells"},{"key":"10.1016\/j.jogc.2022.08.018_bib18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/IGC.0000000000000639","article-title":"Outcomes of incidental fallopian tube high-grade serous carcinoma and serous tubal intraepithelial carcinoma in women at low risk of hereditary breast and ovarian cancer","volume":"26","author":"Chay","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogc.2022.08.018_bib19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ygyno.2013.12.009","article-title":"Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations","volume":"132","author":"Conner","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2022.08.018_bib20","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s12094-018-1865-9","article-title":"Pathology findings and clinical outcomes after risk reduction salpingo-oophorectomy in BRCA mutation carriers: a multicenter Spanish study","volume":"20","author":"Minig","year":"2018","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.jogc.2022.08.018_bib21","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/IGC.0000000000000791","article-title":"Incidence and characteristics of unsuspected neoplasia discovered in high-risk women undergoing risk reductive bilateral salpingooophorectomy","volume":"26","author":"Poon","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogc.2022.08.018_bib22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ygyno.2013.01.029","article-title":"Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy","volume":"129","author":"Powell","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogc.2022.08.018_bib23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2012.07.021","article-title":"Support of the \u201cfallopian tube hypothesis\u201d in a prospective series of risk-reducing salpingo-oophorectomy specimens","volume":"49","author":"Reitsma","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jogc.2022.08.018_bib24","first-page":"5241","article-title":"Risk-reducing salpingo-oophorectomy in women at higher risk of ovarian and breast cancer: a single institution prospective series","volume":"37","author":"Ricciardi","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jogc.2022.08.018_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejogrb.2020.01.040","article-title":"The incidence of occult ovarian neoplasia and cancer in BRCA1\/2 mutation carriers after the bilateral prophylactic salpingo-oophorectomy (PBSO): a single-center prospective study","volume":"247","author":"Rudaitis","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogc.2022.08.018_bib26","first-page":"50","article-title":"Development of peritoneal carcinoma in women diagnosed with serous tubal intraepithelial carcinoma (STIC) following risk-reducing salpingo-oophorectomy (RRSO)","volume":"12","author":"Stanciu","year":"2019","journal-title":"J\u00a0Ovarian Res"},{"key":"10.1016\/j.jogc.2022.08.018_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.gore.2019.01.010","article-title":"Evaluation of screening and risk-reducing surgery for women followed in a high-risk breast\/ovarian cancer clinic: it is all about the tubes in BRCA mutation carriers","volume":"28","author":"Stewart","year":"2019","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.jogc.2022.08.018_bib28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.clon.2018.03.036","article-title":"Outcome and prognostic impact of surgical staging in serous tubal intraepithelial carcinoma: a cohort study and systematic review","volume":"30","author":"Van der Hoeven","year":"2018","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.jogc.2022.08.018_bib29","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/IGC.0b013e3182a80ac8","article-title":"Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC)","volume":"23","author":"Wethington","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogc.2022.08.018_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygyno.2016.08.336","article-title":"Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers","volume":"143","author":"Zakhour","year":"2016","journal-title":"Gynecol Oncol"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216322006120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216322006120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:42:07Z","timestamp":1761666127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216322006120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1701216322006120"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2022.08.018","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome and Management of Serous Tubal Intraepithelial Carcinoma Following Opportunistic Salpingectomy: Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2022.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}